Key facts: AbbVie (ABBV) achieved a new 52-week high of $244.04, accompanied by a trading volume of 6,931,847 shares.
阅读少于1分钟
- AbbVie (ABBV) achieved a new 52-week high of $244.04, accompanied by a trading volume of 6,931,847 shares.1
- AbbVie is expanding its bioresearch center in Worcester, Massachusetts, with a $70 million investment. This project is part of a $10 billion effort to boost U.S. biologics manufacturing.2
- AbbVie has secured a supplier agreement for its Natrelle® product line with Vizient, a prominent healthcare performance improvement company.3